Hong Kong, China vs Timor-Leste: Tuberculosis patients living with HIV receiving antiretroviral therapy

Hong Kong, China
27 patients
in 2021
Timor-Leste
31 patients
in 2021
Hong Kong, China rank
96th
Timor-Leste rank
94th

Tuberculosis patients living with HIV receiving antiretroviral therapy over time

  • Hong Kong, China
  • Timor-Leste
010203040200320122021

How they compare

Timor-Leste currently reports 31 patients against 27 patients in Hong Kong, China, a difference of 4 patients.

That makes Timor-Leste's figure about 1.1 times Hong Kong, China's.

The two have swapped places 1 time across 13 shared years of data; in 2003 it was Hong Kong, China ahead.

Hong Kong, China ranks 96th and Timor-Leste ranks 94th of 183 countries.

Across the 3 decades both report, Hong Kong, China averaged higher in 1 and Timor-Leste in 2.

Head to head by decade

Decade Hong Kong, China Timor-Leste Difference Ahead
2000s 16 patients 0.3333 patients 15.67 patients Hong Kong, China
2010s 9.6 patients 28.2 patients 18.6 patients Timor-Leste
2020s 17.5 patients 35 patients 17.5 patients Timor-Leste

Averages of every year both report within each decade.

Frequently asked questions

Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Hong Kong, China or Timor-Leste?
Timor-Leste, at 31 patients against 27 patients in Hong Kong, China as of 2021.
What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Hong Kong, China and Timor-Leste?
4 patients, with Timor-Leste ahead.
How many years of comparable data are there for Hong Kong, China and Timor-Leste?
13 years are reported by both, from 2003 to 2021.
How do Hong Kong, China and Timor-Leste rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
Hong Kong, China ranks 96th and Timor-Leste ranks 94th of 183 countries.
Where does this data come from?
Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Hong Kong, China vs Timor-Leste: Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data. Retrieved 16 September 2026, from https://health.statizoid.com/compare/tb-patients-living-with-hiv-receiving-art/hong-kong-sar-china/timor-leste/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/tb-patients-living-with-hiv-receiving-art/hong-kong-sar-china/timor-leste/">Hong Kong, China vs Timor-Leste: Tuberculosis patients living with HIV receiving antiretroviral therapy</a> — Statizoid

About this data

Indicator
Tuberculosis patients living with HIV receiving antiretroviral therapy
Unit
patients
Source
Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
183 places, 2,780 data points, 2000–2021
Last refreshed

Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.